Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Predicting Cancer Drug Combinations That Work

Posted on August 6th, 2020 by

Dr. Bart Westerman is a Group Leader and Assistant Professor at the VU University Medical Center in Amsterdam. There he heads research projects in neuro-oncology, as well as in the use of bioinformatics to tackle complex, multidimensional questions to transform cancer therapy decision-making and management. He and his colleagues recently published a cancer drug atlas that predicts synergistic combination therapies for cancer.

(more…)

Research Data Alliance Releases Guidelines for COVID-19 Data Sharing

Posted on July 24th, 2020 by

The Research Data Alliance (RDA) has released its final version of the RDA COVID-19 Recommendations and Guidelines on data sharing for COVID-19, which covers four main research areas: clinical data, omics practices, epidemiology and social sciences. The document also touches on issues like community participation, legal and ethical considerations, research software and indigenous data.

(more…)

To Be a Digital Pharma Player, You Need Data – Reusable Data

Posted on July 21st, 2020 by

A new paper published in Drug Discovery Today finds that the pharmaceutical industry is in an “early mature” phase of using artificial intelligence in R&D, which means that major industry players are interested in and pursuing AI, but not as actively as one might expect. For instance, they note that of the top 20 pharma companies that they looked at, only two (Novartis and Johnson & Johnson) have commercialized AI through products and services so far.

(more…)

The Dawn of a European Health Data Space – Challenges

Posted on July 16th, 2020 by

The European data strategy aims to construct common data spaces for all, create a single EU market for data, and catalyze a dynamic data economy. In a previous post, we briefly described the essence of the envisioned heath data space and pointed at opportunities and possible starting points to transform this vision into reality.

(more…)

  1. 1
  2. 2
  3. 3
  4. 4
  5. 84